EU orders 100 million additional doses from Biontech

The European Union has exercised its option  to order 100 million additional doses of BNT162b2 bringing its orders to 600 million doses at €14.70 per shot.

Read more

Next-gen COVID-19 vaccine good in preclinical tests

Intravacc has announced positive data for its nasal SARS-CoV-2 vaccine that embeds the viral spike antigen in bacterial Outer Membrane Vesicles (OMV)

Read more

EMA: AZD1222 causes serious rare ADEs

In a new statement, the EU regulatory authority EMA postulates that AstraZeneca’s vaccine causes serious deep vein thrombosis.

Read more

Targeting SARS-CoV-2 differently

German structural biologists have identified seven compounds that neutralise SARS-CoV-2 by targeting Mpro, the virus’ main protease.

Read more

Janssen to pledge COVID-19 vaccine to African Union

Johnson & Johnson subsidiary Janssen Pharmaceutica NV has confirmed to deliver 220 million doses of its COVID-19 vaccine to the African Vaccine Acquisition Trust (AVAT).

Read more